Flamingo Therapeutics

Foundation date

04/07/2019

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

The core business of Flamingo Therapeutics is the development of novel and innovative drugs for specific cancer types.

Upcoming events

Latest news

  • SeptiCyte® RAPID receives 510(k) clearance by US FDA

    23 hours ago

  • QbD and Inovigate launch Health to Market, a contract commercialization organization in life sciences

    23 hours ago

  • Dimitrios Mantzilas joins Precirix as Chief Technology Officer

    23 hours ago

Jobs by Flamingo Therapeutics